Conference - Orlando, FL, United States
This AACR Precision Medicine Series conference will focus on the critical points at which cancer becomes resistant to treatment. Research presented will address acquired resistance (secondary genetic alterations or changes in signaling pathways), adaptive resistance (DNA/RNA/protein or microenvironment-mediated), preexisting resistance from tumor heterogeneity or clonal selection, and lessons learned from “extreme” responders to therapy. This conference will also focus on new technologies, diagnostics, and noninterventional assessments to detect emerging resistance to treatment. Elucidating resistance mechanisms and exploiting cancer vulnerabilities to therapeutics will ultimately improve cancer therapy and patient care. This conference explores topics that will appeal to clinicians, as well as, basic, translational, and clinical scientists ranging from academics to industry.
Organization: American Association for Cancer Research - AACR
AACR Precision Medicine Series Drug Sensitivity and Resistance: Improving Cancer Therapy
Wed, Jun 18, 2014 - Sat, Jun 21, 2014
Hyatt Regency Grand Cypress, One Grand Cypress Blvd, Orlando, FL 32836
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.